paromomycin

paromomycin Structure
CAS No.
7542-37-2
Chemical Name:
paromomycin
Synonyms
Aminosidine;R 400;Humycin;Catenulin;Aminosidin;Gabromycin;Paucimycin;Crestomycin;Amminosidin;Gabbromycin
CBNumber:
CB6911922
Molecular Formula:
C23H45N5O14
Molecular Weight:
615.63
MOL File:
7542-37-2.mol
MSDS File:
SDS
Modify Date:
2023/5/15 10:43:33

paromomycin Properties

alpha D25 +65 ±3°
Boiling point 658.93°C (rough estimate)
Density 1.3753 (rough estimate)
refractive index 1.7500 (estimate)
solubility Methanol (Slightly), Water (Slightly)
form Solid
pka 12.93±0.70(Predicted)
color Off-White to Pale Beige
Stability Hygroscopic

SAFETY

Risk and Safety Statements

Toxicity LD50 in rats, mice (mg/kg): >1625, >2275 orally; >650, 423 s.c.; 156, 90 i.v. (Coffey)

paromomycin Chemical Properties,Uses,Production

Description

Paromomycin is recommended for treatment of acute and chronic forms of intestinal amobiasis, as well as for treating intestinal bacteria Salmonella and Shigella. Synonyms of this drug are aminosidine, catenulin, crestomycin, hydroxymycin, monomycin, zygomycyn, and others.

Indications

The antibacterial activity and indications for using paromomycin are analogous to those of neomycin. In addition, it is recommended for treating severe and chronic forms of gastric amebiasis. Synonyms of this drug are aminosidine, catenulin, crestomycin, hydroxymycin, monomycin, zygomycyn, and others.

World Health Organization (WHO)

Paromomycin, an aminoglycoside antibiotic was introduced into medicine in 1959 for the treatment of protozoal, helminthic and bacterial infections. It has been associated, particularly when used by parenteral route, with severe adverse effects including renal damage, neuromuscular blockage and ototoxicity, possibly leading to deafness in some patients. This route of administration is now considered obsolete. However, parenteral dosage forms of paromomycin may still remain available in certain countries.

Antimicrobial activity

A fermentation product of Streptomyces rimosus var. paromomycinus, supplied as the sulfate. The commercial product is a mixture of the two isomeric paromomycins I and II, which are closely related to neomycin.
The antibacterial activity is almost identical to that of neomycin. Since it differs from neomycin in having a hydroxyl rather than an amino group at the 6′-position it is not sensitive to AAC(6′) modifying enzymes. It is active against M. tuberculosis, including multidrug-resistant strains, and the M. avium complex.
Unlike other aminoglycosides, paromomycin is active against some protozoa, including Entamoeba histolytica, Cryptosporidium parvum, Leishmania spp., Giardia lamblia and Trichomonas vaginalis. It also exhibits activity against the tapeworms Taenia saginata, Taenia solium, Diphyllobothrium latum and Hymenolepis nana.
It closely resembles neomycin in pharmacokinetic behavior and liability to produce deafness and intestinal malabsorption.

Clinical Use

Intestinal amebiasis (oral)
Cutaneous leishmaniasis (topical) and visceral leishmaniasis (intramuscular)
Nitroimidazole-resistant trichomoniasis (topical)
Its antiprotozoal activity has attracted some attention, but it has largely been superseded by more active and less toxic compounds. Success in treating nitroimidazole-resistant trichomoniasis with topical paromomycin has been reported. Trials in India and East Africa of parenteral paromomycin alone, or in combination with sodium stibogluconate, for treatment of visceral leishmaniasis have shown promising results.

paromomycin Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 25)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry
BOC Sciences +1-631-485-4226 United States 19553 58 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29826 58 Inquiry
AFINE CHEMICALS LIMITED +86-0571-85134551 China 15395 58 Inquiry
Dayang Chem (Hangzhou) Co.,Ltd. 571-88938639 +8617705817739 China 52861 58 Inquiry
PT CHEM GROUP LIMITED +86-85511178 +86-85511178 China 35451 58 Inquiry
GIHI CHEMICALS CO.,LIMITED +8618058761490 China 49999 58 Inquiry
China National Standard Pharmaceutical Corporation Limited +8615391658522 China 11927 58 Inquiry
Gihi Chemicals Co., Limited +86-0571-86217390 +8618058761490 China 998 58 Inquiry
QUALITY CONTROL SOLUTIONS LTD. 13670046396 China 18865 58 Inquiry

7542-37-2(paromomycin)Related Search:

PAROMOMYCIN,O-2-AMINO-2-DEOXY-ALPHA-D-GLUCOPYRANOSYL-(1-4)-O-[O-2,6-DIAMINO-2,6-DIDEOXY--L-IODOPYRANOSYL-(1-3)--D-RIBOFURANOSYL-(1-5)]-2-DEOXY-D-STREPTAMINE Paromomycinsulfat Aminosidin Aminosidine I Amminosidin Antibiotic 2230D Antibiotic 503-3 Antibiotic SF 767B Crestomycin D-Streptamine, O-2-amino-2-deoxy-a-D-glucopyranosyl-(14)-O-[O-2,6-diamino-2,6-dideoxy-b-L-idopyranosyl-(13)-b-D-ribofuranosyl-(15)]-2-deoxy- (9CI) Gabbromicina Gabbromycin Gabromycin Humycin Hydroxymycin (6CI) Monomycin A Paromomycin I Paromomycine Paucimycin Quintomycin C R 400 Streptamine, O-2,6-diamino-2,6-dideoxy-b-L-idopyranosyl-(13)-O-b-D-ribofuranosyl-(15)-O-[2-amino-2-deoxy-a-D-glucopyranosyl-(14)]-2-deoxy- (8CI) Zygomycin A1 (7CI) 4-O-(2-Amino-2-deoxy-α-D-glucopyranosyl)-5-O-[3-O-(2,6-diamino-2,6-dideoxy-β-L-idopyranosyl)-β-D-ribofuranosyl]-2-deoxy-D-streptamine Hydroxymycin Catenulin paromomycin D-Streptamine, O-2,6-diamino-2,6-dideoxy-β-L-idopyranosyl-(1→3)-O-β-D-ribofuranosyl-(1→5)-O-[2-amino-2-deoxy-α-D-glucopyranosyl-(1→4)]-2-deoxy- Framycetin Impurity 5 (Framycetin EP Impurity E) Aminosidine Framycetin Sulfate Impurity 5 (Framycetin Sulfate EP Impurity E) 7542-37-2